Sangamo to sell ST-920 Fabry assets to PTC for $111 million
Sangamo Therapeutics plans to sell its ST-920 Fabry assets to PTC for $111 million, plus milestones.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.